NFKB1 and colorectal cancer: The monoterpene thymol has exhibited anti-inflammatory, antioxidant, and antitumor potential through free radical scavenging [101], cyto/genotoxic effects on colorectal cancer cells [102], NFκB and MAPK inhibition, and downregulation of COX-2 expression, inflammatory cytokine production, and NO production in murine colitis models and in vitro studies [47,103].